Skip to content

Author

Giuseppe Papa

We have 3 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Practical Guidance for the Use of Control-IQ Technology During Physical Activity and Exercise.

INTRODUCTION Use of automated insulin delivery (AID) systems during physical activity and exercise (PA) is safe and associated with improved glucose outcomes when compared with insulin pump therapy in manual mode and insulin pen therapy, provided that appropriate adjustments to insulin doses and carbohydrate intake are...

S. Di Molfetta, J. Haxhi, F. Franco et al. · 0 citations
Review Open access Aug 2026

Gender Differences in Diabetes Technology: Adherence and Outcomes—A Systematic Review

Background/Objectives: Diabetes management technologies—including continuous glucose monitors (CGM), insulin pumps (CSII), advanced hybrid closed-loop (AHCL) systems, and mobile health applications—have transformed diabetes care, yet gender-specific differences in ad-herence, clinical outcomes, and patient-reported out...

S. La Vignera, A. Calogero, R. Cannarella et al. · 0 citations
Open access Jul 2026

Effect of Active Insulin Time and Glycemic Targets on Automatic Correction Bolus Delivery.

Active insulin time is a key modifiable parameter influencing AB delivery and glycemic outcomes, and shorter AIT settings were associated with increased AB administration and improved TIR, whereas glucose target settings had no significant impact on these outcomes.

Giuseppe Papa, R. Cannarella, C. Gusmano et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.